ARCI backs enhanced NSAID and corticosteroid regs
Following a meeting on Monday, Aug. 5, the Drug Testing Standards and Practices (DTSP) Committee of the Association of Racing Commissions International (ARCI) endorsed instituting a 48-hour restriction on administration of nonsteroidal anti-inflammatory drugs (NSAIDS), which include Phenylbutazone, and a 14-day restriction on the administration of corticosteroids, pending scientific review.
The restriction on corticosteroids would not apply to harness racing, as the sport is currently amidst proceedings to determine breed-specific rules due to different race schedules for Thoroughbreds, Standardbreds and Quarter Horses.
The corticosteroids were previously included in the Model Rules but were removed per the instructions of the Racing Medication & Testing Consortium (RMTC). In a recent meeting of the RMTC, that organization recommended the 48-hour restriction on NSAIDs as the science is available to prove administration after that window can compromise a pre-race examination.
“There have been situations, specifically in New York, where these restrictions have been implemented and been quite successful,” said Ed Martin, ARCI president and past executive director of the New York Gaming and Wagering Board.
LATEST BUSINESS NEWS
Monmouth Park will kick off its 53-day 2021 schedule May 28, with the meet highlighted by the July 17 card featuring the Grade 1 Haskell and United Nations.
Street Lute keeps it rolling, Triple Crown winner Hall of Fame nominees are announced, and a lawsuit roils the industry, in the week in social media.
A circuit court judge ruled that the Maryland Racing Commission’s hearing procedures deprived petitioners of a fair hearing and remanded a case involving the 2020 Geisha Stakes.
Want to check out our “Truth to Power” panel? Here’s the livestream to do so, The panel starts at 5:00 pm EST.
The Jockey Club today announced the release of its national Fact Book for 2021, with wagering, racing, and breeding data.
The Racing Biz today announced that, working in partnership, it will hold a series of virtual panel discussions focusing on race and social justice issues in the industry.